Lilly Eli Co stock is traded at $1,417.99, with a volume of 3,622,171. It is up +0.61% in the last 24 hours and up +24.07% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,409.38
Open:
$1,440.00
24h Volume:
3,622,171
Relative Volume:
1.18
Market Cap:
$1.26T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
51.04
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
+10.07%
1M Performance:
+24.07%
6M Performance:
+46.50%
1Y Performance:
+56.36%
1-Day Range:
$1,401.59$1,445.96
1-Week Range:
$1,382.02$1,449.68
52-Week Range:
$850.51$1,449.68
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS